Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 20;13(5):943.
doi: 10.3390/v13050943.

Thoughts on African Swine Fever Vaccines

Daniel L Rock  1
Affiliations

Thoughts on African Swine Fever Vaccines

Daniel L Rock. Viruses. .

Abstract

African swine fever (ASF) is an acute viral hemorrhagic disease of domestic swine with mortality rates approaching 100%. Devastating ASF outbreaks and continuing epidemics starting in the Caucasus region and now in the Russian Federation, Europe, China, and other parts of Southeast Asia (2007 to date) highlight its significance. ASF strain Georgia-07 and its derivatives are now endemic in extensive regions of Europe and Asia and are "out of Africa" forever, a situation that poses a grave if not an existential threat to the swine industry worldwide. While our current concern is Georgia-07, other emerging ASFV strains will threaten for the indefinite future. Economic analysis indicates that an ASF outbreak in the U.S. would result in approximately $15 billion USD in losses, assuming the disease is rapidly controlled and the U.S. is able to reenter export markets within two years. ASF's potential to spread and become endemic in new regions, its rapid and efficient transmission among pigs, and the relative stability of the causative agent ASF virus (ASFV) in the environment all provide significant challenges for disease control. Effective and robust methods, including vaccines for ASF response and recovery, are needed immediately.

Keywords: ASF; Africa swine fever; protective immunity; vaccine; virulence and host range genes.

PubMed Disclaimer

Conflict of interest statement

I declare no conflict of interest.

References

    1. Tulman E.R., Delhon G., Ku B., Rock D.L. Asfarviruses. In: Van Etten J., editor. Lesser Known Big DNA Viruses-Current Topics in Microbiology and Immunology. Springer; Berlin/Heidelberg, Germany: 2009.
    1. Chapman D.A.G., Tcherepanov V., Upton C., Dixon L.K. Comparison of the genome sequences of non-pathogenic and pathogenic African swine fever virus isolates. Pt 2J. Gen. Virol. 2008;89:397–408. doi: 10.1099/vir.0.83343-0. - DOI - PubMed
    1. Villeda C.J., Williams S.M., Wilkinson P.J., Vinuela E. Consumption coagulopathy associated with shock in acute ASF. Arch. Virol. 1993;133:467–475. doi: 10.1007/BF01313784. - DOI - PubMed
    1. Villeda C.J., Gomez-Villamandos C., Williams S.M., Hervas J., Wilkinson P.J., Vinuela E. The role of fibrinolysis in the pathogenesis of the haemorrhagic syndrome produced by virulent isolates of ASFV. Thromb. Haemost. 1995;73:112–117. - PubMed
    1. Moulton J., Coggins L. Comparison of lesions in acute and chronic African swine fever. Cornell Vet. 1968;58:364–388. - PubMed

Publication types

MeSH terms

LinkOut - more resources